Lecanemab的危害巨大: 11% 的参与者出现症状性脑水肿;Simufilam安全,今年将完成第三阶双盲

来源: futufutu 于 2024-06-20 10:44:23 [旧帖] [给我悄悄话] 本文已被阅读：次

WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.